Clinical Trials List
Protocol NumberCLEE011Q12101
Completed
2023-10-17 - 2028-12-31
Phase I/II
Recruiting1
ICD-10C47.9
Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified
ICD-10C49.9
Malignant neoplasm of connective and soft tissue, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9171.9
Malignant neoplasm of connective and other soft tissue, site unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 杜佳叡 Division of Family Medicine
- 彭信逢 Division of Radiology
- SHIANN-TANG JOU Division of Pediatrics
- 張修豪 Division of Pediatrics
- 周書緯 Division of Pediatrics
- YUNG-LI YANG Division of Others -
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
186 participants
